BioCancell
Patient-Oriented, Targeted Therapy
   
  Overview - Theragnostics
  Patents
  Publications
  R&D Status

Publications

 Selected publications (PDF files):

  1. Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer, Gene Therapy Molecular Biology, Vol. 8, 181-192, 2004
  2. Regulatory Sequences of H19 and IGF2 Genes in DNA-Based Therapy of Colorectal Rat Liver Metastases, Journal of Genetic Medicine, 2004 Nov 1
  3. The involvement of H19 non-coding RNA in Stress: Implications in cancer development and prognosis, Gene Therapy Molecular Biology, Vol. 8, 403-412, 2004
  4. The Oncofetal H19 RNA in human cancer, from the bench to the patient, Cancer Therapy Vol 3, Page 1, 2005
  5. A non-invasive QPCR method monitoring DNA based therapy of bladder cancer patients. Vaccine, Volume 24, Issue 17, 3420-3425, 2006
  6. The H19 Non-Coding RNA is Essential for Human Tumor Growth. PLoS One, 2007
  7. Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Overexpressing Superficial Bladder Cancer Refractory to Bacillus Calmette Guerin. Journal of Urology, Accepted for Publication June 2008.
  8. The Oncofetal H19 RNA Connection: Hypoxia, p53 and cancer (abstract).

Complete list of publications